Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Special report
: The Fierce 50 of 2024
ESMO
Pharma
ESMO: Padcev-Keytruda combo nearly doubles survival in key trial
Seagen and Astellas' Padcev, in combination with Merck's Keytruda, may be transformative in treating bladder cancer, according to new trial results.
Kevin Dunleavy
Oct 22, 2023 10:17am
At ESMO, Merck touts Welireg's potential in kidney cancer
Oct 21, 2023 9:00am
ESMO: Searching for the perfect cup of pharma-branded espress-MO
Oct 20, 2023 7:59am
